Loading clinical trials...
Loading clinical trials...
Double-blind, Randomized Phase II Clinical Trial of Sulindac for Reducing Breast Density in Postmenopausal Women at Risk of Developing Breast Cancer
Conditions
Interventions
Sulindac Pill
Placebo
Locations
2
United States
Cedars Sinai - Cancer
Los Angeles, California, United States
Stony Brook University Cancer Center
Stony Brook, New York, United States
Start Date
November 20, 2020
Primary Completion Date
April 22, 2025
Completion Date
May 19, 2025
Last Updated
June 3, 2025
NCT07040891
NCT07547774
NCT06257264
NCT04740697
NCT07525869
NCT07347600
Lead Sponsor
Alison Stopeck
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions